{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:32:47Z","timestamp":1767861167700,"version":"3.49.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1001\/jamadermatol.2019.3064","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T13:30:26Z","timestamp":1571837426000},"page":"1410","source":"Crossref","is-referenced-by-count":16,"title":["A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018"],"prefix":"10.1001","volume":"155","author":[{"given":"Ashley B.","family":"Pournamdari","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"School of Medicine, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tkachenko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adewole S.","family":"Adamson","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Medicine, Dell Medical School at The University of Texas at Austin, Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"14","key":"drv190002r1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/jama.2012.362","article-title":"Eliminating waste in US health care.","volume":"307","author":"Berwick","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"drv190002r2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.280.11.1000","article-title":"The urgent need to improve health care quality.","volume":"280","author":"Chassin","year":"1998","journal-title":"JAMA"},{"key":"drv190002r3","doi-asserted-by":"publisher","first-page":"h4534","DOI":"10.1136\/bmj.h4534","article-title":"Setting a research agenda for medical overuse.","volume":"351","author":"Morgan","year":"2015","journal-title":"BMJ"},{"issue":"18","key":"drv190002r4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1001\/jama.2017.16193","article-title":"The high costs of unnecessary care.","volume":"318","author":"Carroll","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"drv190002r5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jamainternmed.2018.3573","article-title":"Development of a conceptual map of negative consequences for patients of overuse of medical tests and treatments.","volume":"178","author":"Korenstein","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"drv190002r7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamadermatol.2019.0152","article-title":"Use of antibiotics for dermatologic procedures from 2008 to 2016.","volume":"155","author":"Barbieri","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"drv190002r8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jaad.2017.12.034","article-title":"High-value dermatology, 5: laboratory tests to reconsider.","volume":"78","author":"Ogbechie-Godec","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"drv190002r9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","article-title":"Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis.","volume":"152","author":"Lee","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"9","key":"drv190002r10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne.","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"drv190002r11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamadermatol.2016.4736","article-title":"Helping patients decide on treatment options for actinic keratosis\u2014living in cryo nation.","volume":"153","author":"Roman","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"10","key":"drv190002r12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jamadermatol.2014.1164","article-title":"The impact dermatologists can have on misdiagnosis of cellulitis and overuse of antibiotics: closing the gap.","volume":"150","author":"Hughey","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv190002r13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamainternmed.2014.5444","article-title":"Update on medical overuse.","volume":"175","author":"Morgan","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"11","key":"drv190002r14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jamainternmed.2016.5381","article-title":"2016 Update on medical overuse: a systematic review.","volume":"176","author":"Morgan","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2","key":"drv190002r15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamainternmed.2018.5748","article-title":"2018 Update on medical overuse.","volume":"179","author":"Morgan","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"drv190002r16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2797","article-title":"Update on pediatric overuse.","volume":"139","author":"Coon","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"drv190002r17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamapediatrics.2017.5752","article-title":"2017 Update on pediatric medical overuse: a review.","volume":"172","author":"Coon","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"5","key":"drv190002r18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"issue":"2","key":"drv190002r20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/intqhc\/mzi021","article-title":"The JCAHO patient safety event taxonomy: a standardized terminology and classification schema for near misses and adverse events.","volume":"17","author":"Chang","year":"2005","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"drv190002r21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamadermatol.2017.6196","article-title":"Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial.","volume":"154","author":"Ko","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"drv190002r22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamadermatol.2017.6197","article-title":"Outcomes of early dermatology consultation for inpatients diagnosed with cellulitis.","volume":"154","author":"Li","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"drv190002r23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bjd.16557","article-title":"Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes.","volume":"179","author":"Vuong","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"drv190002r24","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jamadermatol.2018.3359","article-title":"Risk of subsequent cutaneous melanoma in moderately dysplastic nevi excisionally biopsied but with positive histologic margins.","volume":"154","author":"Kim","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"drv190002r25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jaad.2016.08.054","article-title":"Dysplastic nevi with severe atypia: long-term outcomes in patients with and without re-excision.","volume":"76","author":"Engeln","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"drv190002r26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/bjd.2017.177.issue-5","article-title":"Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a critically appraised topic.","volume":"177","author":"Kramer","year":"2017","journal-title":"Br J Dermatol"},{"key":"drv190002r27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/bjd.15207","article-title":"Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.","volume":"177","author":"Opel","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"drv190002r28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jaad.2018.01.030","article-title":"Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.","volume":"78","author":"Stiegel","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"drv190002r29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jid.2017.12.034","article-title":"Cyclosporine for epidermal necrolysis: absence of beneficial effect in a retrospective cohort of 174 patients: exposed\/unexposed and propensity-score matched analyses.","volume":"138","author":"Poizeau","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"drv190002r30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamadermatol.2017.5835","article-title":"Opioid prescribing patterns and complications in the dermatology Medicare population.","volume":"154","author":"Cao","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"drv190002r31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamadermatol.2016.3816","article-title":"Costs and consequences associated with misdiagnosed lower extremity cellulitis.","volume":"153","author":"Weng","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3","key":"drv190002r32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaad.2016.09.009","article-title":"Recurrence of moderately dysplastic nevi with positive histologic margins.","volume":"76","author":"Hiscox","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"drv190002r33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jamadermatol.2018.3578","article-title":"Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections.","volume":"154","author":"Stolmeier","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"drv190002r34","first-page":"329","article-title":"Severe cutaneous adverse reactions due to inappropriate medication use.","volume":"179","author":"Chaby","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"drv190002r35","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","article-title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.","volume":"178","author":"Drucker","year":"2018","journal-title":"Br J Dermatol"},{"issue":"7","key":"drv190002r36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1053\/ajem.2001.28330","article-title":"ED management of cellulitis: a review of five urban centers.","volume":"19","author":"Dong","year":"2001","journal-title":"Am J Emerg Med"},{"issue":"11","key":"drv190002r37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143276","article-title":"Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact.","volume":"10","author":"Kaye","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"drv190002r38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ajem.2018.06.037","article-title":"Patient factors associate with nationwide emergency department utilization for cellulitis.","volume":"37","author":"Li","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"12","key":"drv190002r39","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1001\/jamadermatol.2018.3303","article-title":"Observation of moderately dysplastic nevi with positive margins: are we there yet?","volume":"154","author":"Adamson","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"drv190002r40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1067\/mjd.2002.121029","article-title":"Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.","volume":"46","author":"Tripp","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"drv190002r41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jaad.2015.09.055","article-title":"Degree of clinical concern and dysplasia affect biopsy technique and management of dysplastic nevi with positive biopsy margins: Results from a survey of New England dermatologists.","volume":"74","author":"Tong","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"drv190002r42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jamadermatol.2014.2694","article-title":"Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi\/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.","volume":"151","author":"Kim","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"drv190002r43","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jaad.2015.06.061","article-title":"Management of dysplastic nevi: a 14-year follow-up survey assessing practice trends among US dermatologists.","volume":"73","author":"Winkelmann","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"drv190002r44","first-page":"299","article-title":"Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.","volume":"1","author":"Elewski","year":"2005","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"drv190002r47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/jamadermatol.2015.3128","article-title":"Isotretinoin laboratory test monitoring: a call to decrease testing in an era of high-value, cost-conscious care.","volume":"152","author":"Shinkai","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"7","key":"drv190002r48","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma.","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"drv190002r49","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.jid.2018.03.1496","article-title":"Selective use of cyclosporine for Stevens-Johnson syndrome\/toxic epidermal necrolysis may exclude patients with poor prognostic factors.","volume":"138","author":"Noe","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"10","key":"drv190002r50","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches.","volume":"137","author":"Gonz\u00e1lez-Herrada","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"16","key":"drv190002r51","first-page":"1573","article-title":"Trends in opioid analgesic abuse and mortality in the United States.","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"drv190002r52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamadermatol.2013.1871","article-title":"Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients.","volume":"149","author":"Harris","year":"2013","journal-title":"JAMA Dermatol"},{"key":"drv190002r46","volume-title":"BNF 70 (British National Formulary 70)","author":"Joint Formulary Committee","year":"2015"},{"key":"drv190002r6","unstructured":"ABIM Foundation. Choosing Wisely: clinician lists. http:\/\/www.choosingwisely.org\/clinician-lists\/. Published 2017. Accessed October 28, 2018."},{"key":"drv190002r19","unstructured":"Oxford Centre for Evidence-Based Medicine. Levels of evidence. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-basedmedicine-levels-evidence-march-2009\/. Published March 2009. Accessed February 12, 2019."},{"key":"drv190002r45","unstructured":"US Department of Health and Human Services. Sporanox and Lamisil public health advisory, questions and answers. https:\/\/wayback.archive-it.org\/7993\/20170113165142\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm052956.htm. Accessed August 22, 2017."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2753266\/jamadermatology_pournamdari_2019_rv_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T11:36:28Z","timestamp":1576064188000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2753266"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.3064","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}